Dr. Lea K. Krekow works in the field of Oncology. She researched medicine at University of Texas Medical School. She has 1 awards "Meaningful Use Stage 1 Certification". Lea K. Krekow, MD is also a published doctor. She has 2 paper published. The most recent paper is: Adjuvant dose-dense doxorubicin plus cyclophosphamide followed by dose-dense nab-paclitaxel is safe in women with early-stage breast cancer: a pilot study. She is registered with Medicare and accepts Medicare payments.
NPI NUMBER | 1982641361 | |
NPPES Provider LastName | KREKOW | |
NPPES Provider FirstName | LEA | |
NPPES Provider ZIPCode | 760225934 | |
NPPES Provider State | TX | |
Specialty Description | Medical Oncology | |
Total Claim Count | 1440.0 | |
Distinct Opioid Count | 1.0 | |
Opioid Claim Count | 34.0 | |
Percent Opioid Claims | 2.36 |
National Provider Identifier [NPI] | 1982641361 |
Last Name Of The Provider | KREKOW |
First Name Of The Provider | LEA |
View All |
![]() |
Dr. Lee C. Drinkard, MD
![]() ![]() |
![]() |
Dr. Heidi A. Jordan, MD
![]() |